Quebec Public Funding Facilitates Fertility Preservation for Male Cancer Patients
Author(s) -
Marı́a Belén Herrero,
Ainhoa García,
William Buckett,
Togas Tulandi,
Peter Chan
Publication year - 2016
Publication title -
current oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.053
H-Index - 51
eISSN - 1718-7729
pISSN - 1198-0052
DOI - 10.3747/co.23.2793
Subject(s) - sperm , fertility preservation , sperm bank , cryopreservation , medicine , fertility , infertility , cancer , male infertility , gynecology , sperm quality , andrology , biology , population , pregnancy , embryo , genetics , environmental health , microbiology and biotechnology
Sperm cryopreservation remains the only clinically feasible option to preserve male fertility. The quality of counselling provided by the treating physicians and the cost of sperm cryopreservation can both influence a patient's decision about whether to preserve sperm. On 5 August 2010, the Quebec government introduced provincial coverage of assisted reproductive technologies, with sperm cryopreservation included as a covered service. The aim of the present study was to evaluate whether and how such a program affects the behaviour of cancer patients with respect to sperm cryopreservation.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom